“Is curing patients a sustainable business model?”
“The potential to deliver ‘one shot cures’ is one of the most attractive aspects of gene therapy, genetically-engineered cell therapy and gene editing. However, such treatments offer a very different outlook with regard to recurring revenue versus chronic therapies,” Salveen Richter, an analyst for Goldman Sachs, wrote recently in a report to clients, “While this proposition carries tremendous value for patients and society, it could represent a challenge for genome medicine developers looking for sustained cash flow.”
If needed and simplifying even more, one could read synthetically: “curing patients in effective ways is bad for business”. At this point, I would invite everyone to check how huge are the stakes of Goldman Sachs in research, drug development and biotech.
The obvious game of big pharma
So here it is fully revealed and tragically all true, in its perverted logic, the real game of big pharma -if ever there was further clarification needed. Forget real cures, effectively working. What they want is only abiding and paying lifelong subscribers, people that will take a pill for their remaining lifespan, drugs possibly addictive like opioids, just to generate a “sustained cash flow” straight in their pockets. Chronic pills are almost always -literally- the sickening effect of this game, now also so blatantly and hopelessly monopolistic.
In this context, and with a justice system apparently scientifically blind or kept incapable of the perception of relevant facts, big pharma has systemtically corrupted and invaded universities, medical schools, academic and publicly funded research, and most of the scientific peer review system. It has greatly hampered much of the objectivity of scientific research, belittled real independent scientists, transformed research professions market much into a mobbing business.
In the same context, this statement and its obvious bare-logic corollaries, beget even more unsettling questions, like:
1) Do pharma/biotech companies, with their own and the unduly annexed and hijacked “publicly funded” research, actively engage in slowing down specific working cures to certain diseases, promoting instead just chronic palliative or even damaging pseudo-therapies and pseudo-diagnostics?
2) How many and which non-for-profit organizations operating under the facade of donors sponsored trusts, in reality backed by big pharma, operate with the sole purpose of effectively quenching and diverting all other legitimate efforts toward real effective cures?
3) How many companies routinely go their “extra mile” in the same direction, as suggested in the above statement, and seed, spread, or cause diseases in stealth ways, as a perfectly acceptable “business model” to sell more specific drugs or to generate funds toward specific lines of research?
The weird case of transfusions, prions and mad cows
Incidentally, a humble direct experience of my own about a large multinational engaged in the filtration business tells volumes about the problem. The company had one branch dedicated to blood/transfusion filtrations and it was tightly connected with many major stake holders in prion research (mad cow), of the caliber of Nobel laureates. After the analysis of some experimental data, the obvious conclusion was that the “filter” device the company was marketing, was actually causing prion diseases rather than “cleansing” prion tainted blood. Well, no journalist, investigator, prosecutor, judge, nor government agency, nor enforcement entity seemed minimally interested in these rather remarkable criminal facts or in doing anything at all to stop their proceedings.
Instead, the company continued totally undeterred with its plan to spread health-crippling devices, also helped by the fact that the patient’s consent to the use of any medical device, in these cases, is structured more like a bad joke. It happily continued to lavishly sponsor “scientific” programmatic meetings in NY country clubs, where its paid consultants, Nobel laureates and high profile pseudo-neurobiologists, were invited to plan the beefing up of the whole prion business and relative research fundings. Welcome to Wall Street corporate medical research!
Perhaps it is also worthy to remind here how these kinds of disease (like prion amyloidoses, Alzheimer’s, Parkinson, etc.) do strike, taking very severe tolls, to the very essence of the human being, to its very cognitive and intellectual core.
Where are we heading
It is tragicomically funny how uncomfortable truths can only find their way to the public in comedy and fiction.”You know why I like doctors? Because they don’t cure sh*t! … Because there ain’t no money in the cure, the money is in the medicine!” Chris Rock, a famous stand-up comedian, so depicted, already some years ago, what was really happening, with the takeover of medicine by unfettered corporate powers. But watch out, if you are a scientist and also provide data for it; then, even just mentioning bare facts, it is really a very bad idea.
Perhaps, the time for radical changes has come; time to go back to a medicine and physicians that really do cure people, and to researchers that are free to find real and relevant answers. Isn’t there any market demand for real working cures?
Or, perhaps, we are really reaching that critical stage that some call “singularity”, that is the end of our civilization path as we know it, and the transition to that phase, with features impossible to fathom. Just, it won’t be brought upon us by a rogue AI, or an atomic conflict, or an engineered-uncontrolled bacteria or virus.
More trivially, it seems that the same useful idiots, systematically crippling science everywhere, and their reckless big pharma owners, are destroying life and the rest of mankind, beginning with culture and cognitive abilities of single people, and ending up with physical elimination.
If it is actually so, one would also expect that, after destroying everything else, they will end up, rather ingloriously, half-witting and eventually killing themselves also.
Never fear, though; always while accumulating excellent financial yields!